Quotes 5-day view Delayed Nyse
06/28/2022
06/29/2022
06/30/2022
07/01/2022
07/05/2022
Date
65.25(c)
65.81(c)
64.23(c)
65.49(c)
65.39
Last
2 548 931
2 589 593
3 410 822
2 517 686
1 937 565
Volume
-2.19%
+0.86%
-2.40%
+1.96%
-0.15%
Change
Estimated financial data (e) (USD)
Sales 2022
15 751 M
-
-
Net income 2022
1 563 M
-
-
Net Debt 2022
14 134 M
-
-
P/E ratio 2022
21,6x
Yield 2022
1,74%
Sales 2023
16 450 M
-
-
Net income 2023
2 020 M
-
-
Net Debt 2023
12 929 M
-
-
P/E ratio 2023
17,2x
Yield 2023
1,93%
Capitalization
32 976 M
32 976 M
-
EV / Sales 2022
2,99x
EV / Sales 2023
2,79x
Nbr of Employees
60 000
Free-Float
73,5%
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- kidney dialysis drugs and equipment (30.5%);
- systems for delivering medications and intravenous therapy (25.5%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral...
Ratings of Baxter International Inc.
All news about BAXTER INTERNATIONAL INC.
News in other languages on BAXTER INTERNATIONAL INC.
Analyst Recommendations on BAXTER INTERNATIONAL INC.
Exclusive-3G founders launch investment partnership with former Third Point co-CIO Islam
Chart BAXTER INTERNATIONAL INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAXTER INTERNATIONAL INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
14
Last Close Price
65,39 $
Average target price
84,62 $
Spread / Average Target
29,4%
Please enable JavaScript in your browser's settings to use dynamic charts.